Fact.MR – A Market Research and Competitive Intelligence Provider: The global apheresis market is projected to grow by 2x during the forecast period between 2020 to 2025, estimates Fact.MR.
Demand in Apheresis Market to Burgeon with Increasing Paid Blood Donation Plans
Fact.MR’s latest report on the global apheresis market provides a detailed analysis of leading segments in terms of end-user, technology, procedure, application, product, and region. In addition, it offers a list of key players and various strategies implemented by them to generate high shares in the market.
Fact.MR – A Market Research and Competitive Intelligence Provider: The global apheresis market is projected to grow by 2x during the forecast period between 2020 to 2025, estimates Fact.MR. Emergence of new therapy lines, such as radiotherapy, immunoglobulin therapy, and stem cell therapy to control chronic diseases is expected to drive the growth in apheresis market.
Apheresis is a medical technology that involves removing the blood from a patient or donor and separating it into individual components. It is performed to collect plasma or platelets from the donor, as well as to treat certain chronic medical conditions.
As per Fact.MR, growing unmet need for blood components across the globe is anticipated to propel the growth in the apheresis market. Besides, rising shift towards double dose apheresis from the single dose is likely to surge in the upcoming years.
According to the American Red Cross, every year, approximately 16 million blood components are transfused in the U.S. The organization further states that the country requires about 29,000 units of red blood cells every day.
If You Want To Know More About The Report, Visit
https://www.factmr.com/connectus/sample?flag=S&rep_id=4352
“Rapid shift towards double dose apheresis is expected to increase the demand for separating multiple blood components significantly. Hence, introduction of immunoadsorbent and plasma separators is anticipated to create new opportunities for key players,” says a Fact.MR analyst.
Key Takeaways:
- Based on application, the neurology segment is expected to generate the lion’s share on the back of the increasing usage of evidence-based apheresis procedures.
- In terms of application, cancer segment is anticipated to remain in the second position in terms of share owing to the higher usage of chemotherapy and radiotherapy.
- Based on product, the disposable segment is projected to lead because of the availability of novel apheresis equipment for differentiating between tubing and blood lines.
- By end-user, the blood collection centers segment is set to dominate because of the surging number of blood component donations.
- In terms of technology, the centrifugation segment is anticipated to remain at the forefront owing to its ability to separate all types of blood components.
- North America is set to exhibit a 10% CAGR in the near future owing to the increasing investments by governments to conduct research & development activities in the U.S.
Growth Drivers:
- Increasing adoption of apheresis equipment within hospitals to reduce the dependency of patients on private blood collection centers is expected to boost the market.
- Availability of paid plans in private blood collection centers to attract more donors is anticipated to propel the growth in this market.
- Introduction of various healthcare insurance programs by governments, such as Medicaid and Medicare to provide low-cost apheresis procedures is likely to aid the growth.
Restraints:
- Rising acquisition cost of well-informed resources owing to the scarcity of expert operators may hamper the growth in the market.
To learn more about Apheresis Market, you can get in touch with our Analyst at
https://www.factmr.com/connectus/sample?flag=AE&rep_id=4352
Competitive Landscape
Key players operating in the global apheresis market are mainly focusing on research & development activities to come up with state-of-the-art products. Meanwhile, a few others are engaging in partnerships and acquisitions to co-develop novel products and gain a competitive edge in the market.
For instance,
- December 2021: Immunicom, Inc., a non-drug-based cancer therapy provider, showcased its preliminary data from an ongoing clinical trial at the Society for Immunotherapy of Cancer (SITC) 2021’s annual meeting. The trial is exploring the efficacy of Immunopheresis therapy for solid cancers, such as resistant melanoma. The company is using subtractive LW-02 column to eliminate immunosuppressive soluble tumor necrosis factor receptors (sTNF-Rs) through apheresis.
- November 2021: Terumo Blood and Cell Technologies, a medical technology firm based in the U.S., signed a co-commercialization agreement with Immunicom, Inc. This agreement would enable the combination of Immunicom's LW-02 Column with the former’s Spectra Optia Apheresis System. It will be further used in the treatment of patients with advanced refractory Triple Negative Breast Cancer (TNBC).
- November 2021: The blood bank of Swaroop Rani Nehru hospital in Uttar Pradesh announced that it would be providing ‘Jumbo pack platelet’ for patients suffering from dengue. The pack is also known as single donor apheresis platelets and it is capable of increasing around 50,000 platelets in dengue patients.
Key Players in the Apheresis Market Include:
- Asahi Kasei Corporation
- B. Braun Melsungen AG
- Kaneka Corporation
- FRESENIUS SE & CO. KGAA (Fresenius Kabi AG)
- Otsuka Holdings Co. Ltd
- Terumo corporation (Terumo BCT)
- Haemonetics Corporation
- Macopharma SA
- Mallinckrodt PLC
- Nikkiso Co. Ltd
- Sumitomo Bakelite Company Limited (Kawasumi Laboratories Inc.)
- Cerus Corporation
- Baxter International
- Others
More Valuable Insights on Apheresis Market
Fact.MR provides an unbiased analysis of the apheresis market, presenting historical demand data (2015-2019) and forecast statistics for the period from 2020-2025. The study divulges compelling insights on the global apheresis market with a detailed segmentation on the basis of:
End-user
- Hospitals
- Blood Collection Centers
- Public
- Private
Technology
- Centrifugation
- Membrane Filtration
Procedure
- Plasmapheresis
- Photopheresis
- LDL Apheresis
- Plateletpheresis
- Leukapheresis
- Erythrocytapheresis
- Others (Lymphapheresis and extracorporeal immunoadsorption)
Application
- Renal Diseases
- Neurology
- Hematology
- Cancer
- Autoimmune Diseases
- Cardiovascular Diseases
- Others (Fibrosis and Diabetes)
Product
- Devices
- Disposables
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East &Africa
Key Questions Covered in Apheresis Market Report
- The report offers insight into the apheresis market demand outlook for 2020-2025.
- The market study also highlights projected sales growth for apheresis market between 2020 and 2025.
- Apheresis market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry.
- Apheresis market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others.
Explore Fact.MR’s Coverage on the Healthcare Domain –
Leukapheresis Products Market Insights - An increase in blood donations, increasing endeavours by key companies in the leukapheresis market's industry, and frequent advancements in medical technology and research sciences are all major drivers of the Leukapheresis products market. During the projection period of 2021-2031, the market for leukapheresis products is predicted to rise at a blistering rate. The manufacturing and excessive sales of "Leukopaks," which are supplemented with high concentrations of lymphocytes incorporating leukapheresis products, are one of the clearest instances of demand drivers for leukapheresis product sales.
Plasmapheresis Market Research - The rising prevalence of autoimmune illnesses has resulted in an increase in demand for plasmapheresis around the world. The growing need for extracorporeal therapy is likely to positively impact the global autoimmune disorders market's growth. Type 1 diabetes, celiac disease, rheumatoid arthritis, temporal arteritis, and lupus are just a few of the autoimmune illnesses that are driving growing demand for plasmapheresis. Plasmapheresis is also utilised to treat sickle cell disease and different forms of neurotherapy.
Adsorption Apheresis Devices Market Scope - The market for adsorption apheresis devices is expected to grow significantly over the forecast period, owing to an increase in the number of patients suffering from blood-related, neurological, and other disease problems, as well as an increase in healthcare expenditure in each country to improve hospital infrastructures and healthcare management policies, and an increase in the number of hospitals, which is one of the major factors driving the market for adsorption apheresis devices.
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology to even the most niche categories. 80% of Fortune 1000's trust us in critical decision making.
MarketNgage is powered by Fact.MR – our Unified Intelligence Engine, a revolutionary Market Research Subscription platform with a flexible pricing to suit your needs.
You can access all our healthcare research reports by signing up with MarketNgage’s Market Research Subscription with FREE credits. MarketNgage is powered by Fact.MR – A Fully integrated research solution for seamless single-window access Widest coverage on emerging markets, nascent products, and disruptive technologies.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR